Molecular Profiling

Molecular profiling is laboratory testing that examines the genes, proteins, and other molecules in a tumor to understand its specific biological features. For cancers like mesothelioma, it can reveal mutations and markers that guide treatment choices and clinical trial eligibility. It goes beyond looking at cells under a microscope to read the tumor's molecular makeup.

Origin

Molecular profiling grew out of advances in genomics and molecular biology in the late twentieth and early twenty-first centuries, accelerating after the Human Genome Project. It became part of routine oncology as sequencing costs fell and targeted therapies emerged.

Significance in Asbestos Context

For a mesothelioma patient, molecular profiling can identify alterations in genes such as BAP1, NF2, or CDKN2A that inform prognosis and, in some cases, point toward targeted therapies or clinical trials. It can also help confirm the diagnosis and distinguish mesothelioma from other cancers that look similar under the microscope. Ask your oncologist whether tumor profiling has been done and what it showed. From a claims standpoint, molecular findings that confirm mesothelioma strengthen the medical foundation of a case.

Example Sentence

Molecular profiling of the patient's pleural tumor revealed a BAP1 alteration, which helped confirm the mesothelioma diagnosis and informed trial options.

Related Terms

BAP1, Immunohistochemistry, Mesothelioma, Next-Generation Sequencing, Targeted Therapy

Notes

• Ask your oncologist or pathologist whether molecular or genomic profiling was performed on your tumor.
• Preserved tumor tissue (paraffin blocks) may be needed; ask that it be retained.
• Some findings, such as inherited BAP1 changes, can affect family members and warrant genetic counseling.